It has been observed that miR-145 increased CDDP sensitivity of ESCC cells through MRP1 and P-gp downregulations following the AKT3 targeting and subsequent PI3K/AKT inhibition. Here, AKT1 is linked to esophageal squamous cell carcinoma.